Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016, Article ID 8192323, 6 pages
http://dx.doi.org/10.1155/2016/8192323
Review Article

Mollicutes/HIV Coinfection and the Development of AIDS: Still Far from a Definitive Response

1Department of Pharmaceutical Sciences, University of Blumenau, 89010-350 Blumenau, SC, Brazil
2Biomedical Sciences School, University of Blumenau, 89010-350 Blumenau, SC, Brazil

Received 26 August 2015; Accepted 31 May 2016

Academic Editor: Caroline Gilbert

Copyright © 2016 Caio Mauricio Mendes de Cordova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Jaiyeoba, G. Lazenby, and D. E. Soper, “Recommendations and rationale for the treatment of pelvic inflammatory disease,” Expert Review of Anti-Infective Therapy, vol. 9, no. 1, pp. 61–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Razin, D. Yogev, and Y. Naot, “Molecular biology and pathogenicity of mycoplasmas,” Microbiology and Molecular Biology Reviews, vol. 62, no. 4, pp. 1094–1156, 1998. View at Google Scholar · View at Scopus
  3. C. S. Bradshaw, S. N. Tabrizi, T. R. H. Read et al., “Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure,” Journal of Infectious Diseases, vol. 193, no. 3, pp. 336–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S.-C. Lo, M. S. Dawson, D. M. Wong et al., “Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study,” American Journal of Tropical Medicine and Hygiene, vol. 41, no. 5, pp. 601–616, 1989. View at Google Scholar · View at Scopus
  5. C. M. M. Cordova, A. Blanchard, and R. A. F. Cunha, “Higher prevalence of urogenital mycoplasmas in human immunodeficiency virus-positive patients as compared to patients with other sexually transmitted diseases,” Journal of Clinical Laboratory Analysis, vol. 14, no. 5, pp. 246–253, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Blanchard, “Mycoplasmas and HIV infection, a possible interaction through immune activation,” Wiener Klinische Wochenschrift, vol. 109, no. 14-15, pp. 590–593, 1997. View at Google Scholar · View at Scopus
  7. C. M. M. de Cordova, K. Takei, C. Rosenthal, M. A. R. B. Miranda, A. J. Vaz, and R. A. F. da Cunha, “Evaluation of IgG, IgM, and IgA antibodies to Mycoplasma penetrans detected by ELISA and immunoblot in HIV-1-infected and STD patients, in Sao Paulo, Brazil,” Microbes and Infection, vol. 1, no. 13, pp. 1095–1101, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. J. I. Glass, E. J. Lefkowitz, J. S. Glass, C. R. Heiner, E. Y. Chen, and G. H. Cassell, “The complete sequence of the mucosal pathogen Ureaplasma urealyticum,” Nature, vol. 407, no. 6805, pp. 757–762, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. González-Jiménez and C. A. Villanueva-Díaz, “Epididymal stereocilia in semen of infertile men: evidence of chronic epididymitis?” Andrologia, vol. 38, no. 1, pp. 26–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. M. Cordova and R. A. F. Cunha, “Relevant prevalence of Mycoplasma hominis and Ureaplasma urealyticum serogroups in HIV-1 infected men without urethritis symptoms,” Revista do Instituto de Medicina Tropical de São Paulo, vol. 42, no. 4, pp. 185–188, 2000. View at Google Scholar · View at Scopus
  11. J. C. Miranda Filho, E. M. Dalmarco, and C. M. de Cordova, “Mycoplasma and ureaplasma infection in women,” Dynamis, vol. 12, no. 48, pp. 79–87, 2004. View at Google Scholar
  12. T. Sasaki, Y. Sasaki, M. Kita, K. Suzuki, H. Watanabe, and M. Honda, “Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains,” Journal of Clinical Microbiology, vol. 30, no. 9, pp. 2435–2440, 1992. View at Google Scholar · View at Scopus
  13. F. Barré-Sinoussi, J. C. Chermann, F. Rey et al., “Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS),” Science, vol. 220, no. 4599, pp. 868–871, 1983. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Montagnier and A. Blanchard, “Mycoplasmas as cofactors in infection due to the human immunodeficiency virus,” Clinical Infectious Diseases, vol. 17, supplement 1, pp. S309–S315, 1993. View at Google Scholar · View at Scopus
  15. J. G. Ainsworth, S. Hourshid, J. Clarke et al., “Detection of Mycoplasma fermentans in HIV-positive individuals undergoing bronchoscopy,” IOM Letters, vol. 3, pp. 19–26, 1994. View at Google Scholar
  16. V. L. Katseni, B. K. Ryait, K. Ariyoshi et al., “Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1,” The Lancet, vol. 341, no. 8840, pp. 271–273, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Taylor-Robinson, “Infections due to species of Mycoplasma and Ureaplasma: an update,” Clinical Infectious Diseases, vol. 23, no. 4, pp. 671–684, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. G. H. Cassel, A. Yanez, and L. B. Duddy, “Detection of Mycoplasma fermentans in the respiratory tract of children with pneumonia,” IOM Letters, vol. 3, article 546, 1994. View at Google Scholar
  19. S. Lo, H. Kotani, and W. S. Hu, “Molecular and cell biology of opportunistic infections in AIDS. Mycoplasmas and AIDS,” Molecular and Cell Biology of Human Diseases Series, vol. 2, pp. 229–256, 1993. View at Google Scholar · View at Scopus
  20. D. Taylor-Robinson and P. M. Furr, “Genital mycoplasma infections,” Wiener Klinische Wochenschrift, vol. 109, no. 14-15, pp. 578–583, 1997. View at Google Scholar · View at Scopus
  21. T. Deguchi, C. B. Gilroy, and D. Taylor-Robinson, “Failure to detect Mycoplasma fermentans, Mycoplasma penetrans, or Mycoplasma pirum in the urethra of patients with acute nongonococcal urethritis,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 15, no. 2, pp. 169–171, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. J. G. Ainsworth, V. Katseni, S. Hourshid et al., “Mycoplasma fermentans and HIV-associated nephropathy,” Journal of Infection, vol. 29, no. 3, pp. 323–326, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Sasaki, A. Blanchard, H. L. Watson et al., “In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals,” Infection and Immunity, vol. 63, no. 11, pp. 4277–4283, 1995. View at Google Scholar · View at Scopus
  24. R. Nir-paz, S. Israel, A. Honigman, and I. Kahane, “Mycoplasmas regulate HIV-LTR-dependent gene expression,” FEMS Microbiology Letters, vol. 128, no. 1, pp. 63–68, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Gaynor, “Cellular transcription factors involved in the regulation of HIV-1 gene expression,” AIDS, vol. 6, no. 4, pp. 347–363, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Shimizu, Y. Kida, and K. Kuwano, “Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors,” Immunology, vol. 113, no. 1, pp. 121–129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Iyama, S. Ono, K. Kuwano, M. Ohishi, H. Shigematsu, and S. Arai, “Induction of tumor necrosis factor alpha (TNFα) and enhancement of HIV-1 replication in the J22HL60 cell line by Mycoplasma penetrans,” Microbiology and Immunology, vol. 40, no. 12, pp. 907–914, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Y.-H. Wang, M. M. Hayes, D. J. Wear et al., “High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients,” The Lancet, vol. 340, no. 8831, pp. 1312–1316, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Grau, B. Slizewicz, P. Tuppin et al., “Association of Mycoplasma penetrans with human immunodeficiency virus infection,” Journal of Infectious Diseases, vol. 172, no. 3, pp. 672–681, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Tuppin, O. Delamare, V. Launay et al., “High prevalence of antibodies to Mycoplasma penetrans in human immunodeficiency virus-seronegative and -seropositive populations in Brazzaville, Congo,” Clinical and Diagnostic Laboratory Immunology, vol. 4, no. 6, pp. 787–788, 1997. View at Google Scholar · View at Scopus
  31. O. Grau, P. Tuppin, B. Slizewicz et al., “A longitudinal study of seroreactivity against Mycoplasma penetrans in HIV-infected homosexual men: association with disease progression,” AIDS Research and Human Retroviruses, vol. 14, no. 8, pp. 661–667, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. A. P. Dos Santos, R. P. Dos Santos, A. W. Biondo et al., “Hemoplasma infection in HIV-positive patient, Brazil,” Emerging Infectious Diseases, vol. 14, no. 12, pp. 1922–1924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. E. Watson Jr. and G. A. Storch, “Recurrent mycoplasma pneumoniae infection in a human immunodeficiency virus-positive child,” Pediatric Infectious Disease Journal, vol. 27, no. 11, pp. 1037–1038, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Brenner, O. Neyrolles, and A. Blanchard, “Mycoplasmas and HIV infection: from epidemiology to their interaction with immune cells,” Frontiers in Bioscience, vol. 1, no. 1, pp. e42–e54, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. B. R. Cullen and W. C. Greene, “Regulatory pathways governing HIV-1 replication,” Cell, vol. 58, no. 3, pp. 423–426, 1989. View at Publisher · View at Google Scholar · View at Scopus
  36. J. G. Ainsworth, S. Hourshid, P. J. Easterbrook, C. B. Gilroy, J. N. Weber, and D. Taylor-Robinson, “Mycoplasma species in rapid and slow HIV progressors,” International Journal of STD and AIDS, vol. 11, no. 2, pp. 76–79, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Badri, R. Ehrlich, R. Wood, T. Pulerwitz, and G. Maartens, “Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 3, pp. 225–232, 2001. View at Google Scholar · View at Scopus
  38. H. López-Gatell, S. R. Cole, N. A. Hessol et al., “Effect of tuberculosis on the survival of women infected with human immunodeficiency virus,” American Journal of Epidemiology, vol. 165, no. 10, pp. 1134–1142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Vanham, K. Edmonds, L. Qing et al., “Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection,” Clinical and Experimental Immunology, vol. 103, no. 1, pp. 30–34, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Wolday, B. Tegbaru, A. Kassu et al., “Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients,” Journal of Acquired Immune Deficiency Syndromes, vol. 39, no. 3, pp. 265–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Srikantiah, J. K. Wong, T. Liegler et al., “Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis,” Journal of Acquired Immune Deficiency Syndromes, vol. 49, no. 4, pp. 458–460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Goletti, S. Carrara, D. Vincenti et al., “Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis,” Journal of Infectious Diseases, vol. 189, no. 4, pp. 624–633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. K. K. Saharia and R. A. Koup, “XT cell susceptibility to HIV influences outcome of opportunistic infections,” Cell, vol. 155, no. 3, pp. 505–514, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. E. M. Shankar, R. Vignesh, R. Ellegård et al., “HIV-Mycobacterium tuberculosis co-infection: a ‘danger-couple model’ of disease pathogenesis,” Pathogens and Disease, vol. 70, no. 2, pp. 110–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Saraya, D. Kurai, K. Nakagaki et al., “Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications,” Frontiers in Microbiology, vol. 5, article 410, 2014. View at Google Scholar
  46. J. Sampaio, C. F. Ceola, L. D. P. N. Machado et al., “Assessment of immunosuppression progress in patients with HIV/AIDS in the presence of urogenital tract mycoplasmas,” Tendencias em HIV/AIDS, vol. 8, no. 1, pp. 8–12, 2013. View at Google Scholar
  47. S. N. Mavedzenge and H. A. Weiss, “Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis,” AIDS, vol. 23, no. 5, pp. 611–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Wang, J.-R. Wu, H.-J. Guo et al., “The prevalence of six species of Mycoplasmataceae in an HIV/AIDS population in Jiangsu Province, China,” International Journal of STD and AIDS, vol. 23, no. 8, pp. e7–e10, 2012. View at Publisher · View at Google Scholar · View at Scopus